I am a
Home I AM A Search Login

Papers of the Week


Papers: 25 Apr 2020 - 1 May 2020


Human Studies, Pharmacology/Drug Development

PAIN TYPE:
Migraine/Headache


2020 Apr 25


J Headache Pain


21


1

Sustained response to onabotulinumtoxin A in patients with chronic migraine: real-life data.

Authors

Ornello R, Guerzoni S, Baraldi C, Evangelista L, Frattale I, Marini C, Tiseo C, Pistoia F, Sacco S
J Headache Pain. 2020 Apr 25; 21(1):40.
PMID: 32334534.

Abstract

Treatment with onabotulinumtoxin A (BT-A) is safe and effective for chronic migraine (CM). Several studies assessed possible predictors of response to treatment with BT-A, but there is little knowledge on the frequency and predictors of sustained response. The aim of this study was to evaluate sustained response to BT-A in patients with CM.